Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$15.56
Net Income/Share$2.40
Operating CF/Share$3.28
Free CF/Share$2.44
Cash/Share$6.00
Book Value/Share$16.71
Tangible Book/Share$4.40
Equity/Share$16.71
Interest Debt/Share$14.68
CapEx/Share$0.84
Dividend/Share$0.00
Valuation
Market Cap$1.22B
Enterprise Value$1.66B
P/E Ratio11.03P/S Ratio1.68P/OCF Ratio8.08
P/FCF Ratio10.75
P/B Ratio1.58P/TB Ratio1.58
EV/Sales2.29EV/EBITDA7.49
Graham Valuation
Graham Number$30.05
Graham Net-Net$-8.77
Profitability
Earnings Yield9.07%FCF Yield9.30%ROE14.80%ROIC8.39%Return on Tangible Assets10.20%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF25.63%
CapEx/Revenue5.39%
CapEx/Depreciation0.68
SBC/Revenue3.69%
SG&A/Revenue11.39%
R&D/Revenue11.15%
Liquidity & Solvency
Debt/Equity0.85Debt/Assets0.39Debt/Market Cap0.54
Net Debt/EBITDA1.99
Current Ratio3.12Interest Coverage5.93xIncome Quality1.36Efficiency
Days Sales Outstanding74 days
Days Payables Outstanding40 days
Days Inventory185 days
Receivables Turnover4.93x
Payables Turnover9.03x
Inventory Turnover1.97x
Capital Structure
Tangible Assets$204.51M
Working Capital$434.24M
Invested Capital$1.36B
Intangibles/Assets34.34%